Bixiye
P26-17 New Drug-Related Prior Authorization (PA) Criteria: Urea Cycle Disorders
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2017
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 2781 - 2790 ee natiijooyinka 3606
Bixiye
P54-16 Added Reimbursement Policies
Taariikhda uu dhaqangalayo Barnaamijka: Nov 14, 2016
Bixiye
P18-17 New Drug-Related Prior Authorization Requirements for Nusinersen (Spinraza)
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2017
Bixiye
P59-18 New Acupuncture Update for Commercial Lines of Business - Effective January 1, 2019
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2018
Bixiye
P59-17 Government Programs Subscribers Prior Authorization Requirement for Spinal Fusion: Lumbar
Taariikhda uu dhaqangalayo Barnaamijka: Nov 01, 2017
Bixiye
P53-17 New Drug-Related Prior Authorization Requirements for Edaravone (Radicava) and Cerliponase Alfa (Brineura)
Taariikhda uu dhaqangalayo barnaamijka: Okt 10, 2017
Bixiye
P58-16 Changes to Prior Authorization for Infertility for Commercial Lines of Business
Taariikhda uu dhaqangalayo Barnaamijka: Nov 28, 2016
Bixiye
P6-18 Addition of Drug to the Self-Administered Oncology PA with QL Program
Taariikhda uu dhaqangalayo Barnaamijka: 01, Feb 2018
Bixiye
P48-16 Criteria Changes to Certain Services on the Prior Authorization List for MHCP Subscribers
Taariikhda uu dhaqangalayo barnaamijka: Okt 26, 2016
Bixiye
P20-17 New Drug-Related Prior Authorization Criteria for QVAR (beclomethasone dipropionate HFA)
Taariikhda uu dhaqangalayo Barnaamijka: May 08, 2017